Early research (Phase 1)Study completedNCT02560220
What this trial is testing
MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients
Who this might be right for
Kidney Failure, Chronic
Heidelberg University 14